BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15035905)

  • 1. Clinical testing of supplementation therapy in early stage breast cancer: pitfalls and opportunities.
    Tripathy D
    Integr Cancer Ther; 2003 Jun; 2(2):160-2. PubMed ID: 15035905
    [No Abstract]   [Full Text] [Related]  

  • 2. Mega-dose vitamin and mineral therapy in breast cancer: a clinician's perspective.
    Block KI
    Integr Cancer Ther; 2003 Jun; 2(2):163-5. PubMed ID: 15035906
    [No Abstract]   [Full Text] [Related]  

  • 3. Breast cancer: non-metastatic.
    Dixon JM; Gregory K; Johnston S; Rodger A
    Clin Evid; 2002 Jun; (7):1603-30. PubMed ID: 12230775
    [No Abstract]   [Full Text] [Related]  

  • 4. Mega-dose vitamins and breast cancer.
    Block KI; Gyllenhaal C
    Integr Cancer Ther; 2003 Jun; 2(2):145-6. PubMed ID: 15035901
    [No Abstract]   [Full Text] [Related]  

  • 5. Comments on "Mega-dose vitamins and minerals in the treatment of nonmetastatic breast cancer: an historical cohort study".
    Hoffer A
    Integr Cancer Ther; 2003 Jun; 2(2):155-7. PubMed ID: 15035903
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple dietary antioxidants enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity.
    Prasad KN
    Integr Cancer Ther; 2004 Dec; 3(4):310-22. PubMed ID: 15523102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy in stage III breast cancer.
    Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
    Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of international treatment guidelines and prognostic tests for the treatment of early breast cancer.
    Muñoz M; Estévez LG; Alvarez I; Fernández Y; Margelí M; Tusquets I; Seguí MA; Lluch A
    Cancer Treat Rev; 2008 Dec; 34(8):701-9. PubMed ID: 18922644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatase inhibitors in the treatment of early and advanced breast cancer.
    Joensuu H; Ejlertsen B; Lønning PE; Rutqvist LE
    Acta Oncol; 2005; 44(1):23-31. PubMed ID: 15848903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant clodronate in breast cancer.
    Paterson AH
    Acta Oncol; 2005; 44(1):80-2; author reply 83-4. PubMed ID: 15848910
    [No Abstract]   [Full Text] [Related]  

  • 11. Get the facts straight.
    Kopans DB
    J Clin Oncol; 2004 Dec; 22(23):4859; author reply 4860-2. PubMed ID: 15570093
    [No Abstract]   [Full Text] [Related]  

  • 12. Palliative approaches to the patient with breast cancer.
    Bartus CM; Schreiber JS; Kurtzman SH
    Surg Oncol Clin N Am; 2004 Jul; 13(3):517-30, ix. PubMed ID: 15236733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of early breast carcinoma before and after the introduction of clinical practice guidelines.
    White V; Pruden M; Giles G; Collins J; Jamrozik K; Inglis G; Boyages J; Hill D
    Cancer; 2004 Aug; 101(3):476-85. PubMed ID: 15274060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin C in alternative cancer treatment: historical background.
    Block KI; Mead MN
    Integr Cancer Ther; 2003 Jun; 2(2):147-54. PubMed ID: 15035902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of alternative therapy in postmenopausal breast cancer patients treated with tamoxifen after surgery.
    Yap KP; McCready DR; Fyles A; Manchul L; Trudeau M; Narod S
    Breast J; 2004; 10(6):481-6. PubMed ID: 15569202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy.
    Huang EH; Tucker SL; Strom EA; McNeese MD; Kuerer HM; Buzdar AU; Valero V; Perkins GH; Schechter NR; Hunt KK; Sahin AA; Hortobagyi GN; Buchholz TA
    J Clin Oncol; 2004 Dec; 22(23):4691-9. PubMed ID: 15570071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer.
    Hébert-Croteau N; Brisson J; Lemaire J; Latreille J; Pineault R
    Cancer; 2005 Oct; 104(7):1343-8. PubMed ID: 16080144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of hormone replacement therapy on postmenopausal breast cancer biology and survival.
    Keskek M; Ozalp N; Tez M
    Am J Surg; 2010 May; 199(5):723. PubMed ID: 20466120
    [No Abstract]   [Full Text] [Related]  

  • 19. 5-year follow-up after sentinel node mapping for breast cancer demonstrates better than expected treatment outcomes.
    Fuhrman GM; Gambino J; Bolton JS; Farr G; Jiang X
    Am Surg; 2005 Jul; 71(7):564-9; discussion 569-70. PubMed ID: 16089119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Breast cancer treatment].
    Duodecim; 2005; 121(3):317-8. PubMed ID: 15787290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.